Status:
UNKNOWN
The Effects Of DBS Of Subthalamıc Nucleus On Functionality In Patıents With Parkinson's Disease: Short-Term Results
Lead Sponsor:
Mustafa Kemal University
Conditions:
Parkinson Disease
Surgery
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
Parkinson's disease is a progressive chronic neurodegenerative disease. In cases where drug treatment is insufficient and drug use is not possible due to drug side effects, highly effective and low-ri...
Detailed Description
In the study, at least 10 patients with Parkinson's disease who had DBS surgery in Mustafa Kemal University Research and Practice Hospital, Department of Brain and Nerve Surgery will be evaluated. Dem...
Eligibility Criteria
Inclusion
- Lack of any neurological disease other than Parkinson's
- DBS surgery to be performed in the STN region
Exclusion
- Patients with advanced cognitive impairment
- Patients with pulmonary, neurological and orthopedic diseases affecting functionalities
- Pregnancy
- Patients in whom the stimulation was canceled due to infection after surgery.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03797976
Start Date
January 1 2018
End Date
December 30 2019
Last Update
March 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hatay Mustafa Kemal University
Antakya, Hatay, Turkey (Türkiye), 30100